Company news

Beyond Air, Inc. news in 2020

Beyond Air, Inc.'s news releases, calls and decks from 2020, newest first.

View company

Beyond Air® Initiates Patient Screening for LungFit™ GO Pilot Study for At-Home, Self-Administration of Inhaled Nitric Oxide in Nontuberculous Mycobacteria Lung Disease

December 6, 2020

Beyond Air® Submits Premarket Approval Application to FDA for LungFit™ PH to Treat Persistent Pulmonary Hypertension of the Newborn

November 10, 2020

Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2021 and Provides Business Update

November 10, 2020

Beyond Air® Schedules Second Fiscal Quarter 2021 Financial Results Conference Call and Webcast

October 22, 2020

Beyond Air® Approved to Initiate Clinical Study at 150 ppm Nitric Oxide with LungFit™ for the Treatment of Acute Viral Pneumonia Including COVID-19

October 20, 2020

Beyond Air® Presents Data Showing Anti-Coronavirus Activity of Nitric Oxide at the CHEST Annual Meeting 2020

October 18, 2020

Beyond Air® Presents Positive New Preclinical Data for the Use of a Single Injection of Gaseous Nitric Oxide as a Novel In situ Cancer Vaccination

October 15, 2020

Beyond Air® to Present Data on Nitric Oxide in the Treatment of Solid Tumors at the American Association for Cancer Research (AACR) Conference on Tumor Immunology and Immunotherapy

September 29, 2020

Beyond Air® Reports Financial Results for First Quarter of Fiscal Year 2021 and Provides Business Update

August 5, 2020

Beyond Air® to Announce Fiscal First Quarter 2021 Financial Results on Thursday, August 6th

July 22, 2020

Calls in 2020

Decks in 2020